| Literature DB >> 35035164 |
Mufaddal Kazi1, Sajid S Qureshi2,3.
Abstract
Pediatric peritoneal sarcomatosis is an exceedingly rare entity with unknown incidence. Within these tumors, primary peritoneal rhabdomyosarcoma constitutes a small fraction. Majority of them are probably treated inadequately and have dismal outcomes. A favorable subset exists where aggressive treatment in the form of cytoreductive surgery supplemented by hyperthermic intraperitoneal chemotherapy in the multimodal setting can be attempted. We present a case of primary peritoneal embryonal rhabdomyosarcoma in a 2-year-old child who was treated with systemic chemotherapy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy while avoiding radiation, with its evidence and rationale. © Indian Association of Surgical Oncology 2021.Entities:
Keywords: Cytoreductive surgery; Embryonal rhabdomyosarcoma; HIPEC; Primary peritoneal rhabdomyosarcoma; Rhabdomyosarcoma; Sarcomatosis
Year: 2021 PMID: 35035164 PMCID: PMC8716744 DOI: 10.1007/s13193-021-01351-3
Source DB: PubMed Journal: Indian J Surg Oncol ISSN: 0975-7651